{"id":2921,"date":"2026-08-26T00:35:06","date_gmt":"2026-08-25T23:35:06","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/en\/?post_type=product&p=2921"},"modified":"2026-08-26T00:35:06","modified_gmt":"2026-08-25T23:35:06","slug":"buy-palmitoyl-tetrapeptide-7-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/en\/product\/buy-palmitoyl-tetrapeptide-7-in-switzerland\/","title":{"rendered":"Palmitoyl Tetrapeptide-7 (200MG)"},"content":{"rendered":"

What Is Palmitoyl Tetrapeptide-7?<\/h2>\n

Palmitoyl Tetrapeptide-7, also known as Rigin or Pal-GQPR, is a synthetic lipopeptide that originates from a fragment of human immunoglobulin G (IgG). The peptide features a tetrapeptide sequence\u2014glycine, glutamine, proline, and arginine (GQPR)\u2014conjugated with a palmitoyl fatty acid chain at the N-terminus, forming Palmitoyl-Gly-Gln-Pro-Arg (Pal-GQPR). This palmitoylation modification significantly enhances the peptide’s lipophilicity, which improves its ability to penetrate biological membranes and increases its stability in research environments.<\/p>\n

Researchers classify Palmitoyl Tetrapeptide-7 as a matrikine-like peptide\u2014a signaling molecule that regulates cellular activities. Even though it does not derive from connective tissue proteins, researchers commonly group it with matrikine peptides because it produces similar effects in promoting collagen and extracellular matrix synthesis. As a palmitoylated IgG fragment, Palmitoyl Tetrapeptide-7 has attracted considerable interest in dermatological, fibroblast, and extracellular matrix research. For those looking to buy Palmitoyl Tetrapeptide-7 in Switzerland<\/strong>, Core Peptides offers high-quality research-grade material for laboratory applications.<\/p>\n

Palmitoyl Tetrapeptide-7 Research Overview<\/h2>\n

Palmitoyl Tetrapeptide-7 represents a well-documented lipopeptide within the broader family of skin and matrix research compounds. The peptide’s design incorporates a palmitoyl group\u2014a 16-carbon saturated fatty acid chain\u2014attached to the N-terminus of the GQPR sequence. This modification serves multiple purposes: it increases the peptide’s fat solubility, protects it from enzymatic degradation, and prolongs its activity in biological systems.<\/p>\n

Research interest in Palmitoyl Tetrapeptide-7 centers on its potential to modulate inflammatory responses and support extracellular matrix integrity. Scientists investigate its ability to downregulate interleukin-6 (IL-6) production, which reduces inflammation and protects the extracellular matrix from degradation. Consequently, while the research continues to evolve, Palmitoyl Tetrapeptide-7 has generated significant interest as a well-documented signaling peptide for matrix and anti-inflammatory research.<\/p>\n

When researchers choose to buy Palmitoyl Tetrapeptide-7 in Switzerland<\/strong> for laboratory studies, they gain access to a compound that may help elucidate mechanisms of fibroblast activation, collagen synthesis, and extracellular matrix remodeling at the molecular level.<\/p>\n

How Does Palmitoyl Tetrapeptide-7 Work?<\/h2>\n

The proposed mechanism of Palmitoyl Tetrapeptide-7 involves the downregulation of interleukin-6 (IL-6) production. Elevated levels of IL-6 are associated with chronic inflammation, which can accelerate the aging process by promoting the expression of matrix metalloproteinases (MMPs)\u2014enzymes responsible for the breakdown of collagen and other extracellular matrix proteins.<\/p>\n

Anti-Inflammatory Mechanism Through IL-6 Suppression<\/h3>\n

In vitro studies have demonstrated that Palmitoyl Tetrapeptide-7 can significantly reduce IL-6 production, with a reported reduction of up to 40% in standard conditions. Moreover, this effect becomes even more pronounced in cells exposed to UV radiation, where an 86% reduction in IL-6 has been observed. By suppressing IL-6, Palmitoyl Tetrapeptide-7 may indirectly modulate downstream inflammatory signaling pathways such as NF-\u03baB and JAK\/STAT.<\/p>\n

Extracellular Matrix Support and Collagen Synthesis<\/h3>\n

Furthermore, by reducing inflammation, Palmitoyl Tetrapeptide-7 creates a more favorable environment for the synthesis of key extracellular matrix components. Researchers have documented that Palmitoyl Tetrapeptide-7 stimulates collagen type I and fibronectin synthesis, which contributes to improved matrix structure and integrity. The peptide supports the integrity of the extracellular matrix by promoting the synthesis of components like collagen and laminin.<\/p>\n

Additional Mechanisms<\/h3>\n

Additionally, Palmitoyl Tetrapeptide-7 appears to increase hyaluronic acid levels in tissues, helping to maintain hydration and structural integrity. Researchers who buy Palmitoyl Tetrapeptide-7 in Switzerland<\/strong> for research purposes can investigate these mechanisms across diverse experimental models.<\/p>\n

Why Is Palmitoyl Tetrapeptide-7 Studied?<\/h2>\n

Researchers study Palmitoyl Tetrapeptide-7 primarily for its potential relevance to fibroblast biology, collagen synthesis, extracellular matrix remodeling, and anti-inflammatory mechanisms. The peptide’s ability to modulate IL-6 production and support ECM integrity makes it a valuable tool for understanding the molecular basis of tissue matrix formation and inflammatory regulation.<\/p>\n

The peptide’s connection to IgG-derived signaling and matrikine-like activity has made it a focus of dermatological and matrix research. Specifically, preclinical studies have explored Palmitoyl Tetrapeptide-7’s effects on collagen production, fibroblast proliferation, and matrix organization.<\/p>\n

Moreover, researchers study Palmitoyl Tetrapeptide-7 in the context of age-related matrix changes, tissue remodeling, and inflammation. As the demand for understanding matrix biology and tissue regeneration grows, Palmitoyl Tetrapeptide-7 represents one well-documented avenue of research inquiry.<\/p>\n

Researchers who buy Palmitoyl Tetrapeptide-7 in Switzerland<\/strong> from Core Peptides can incorporate this peptide into their studies on fibroblast activation, collagen synthesis, IL-6 modulation, and extracellular matrix biology.<\/p>\n

Palmitoyl Tetrapeptide-7 Research Areas<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nDescription<\/th>\n<\/tr>\n<\/thead>\n
Collagen Synthesis<\/strong><\/td>\nInvestigating Palmitoyl Tetrapeptide-7’s potential to stimulate collagen type I production in fibroblasts<\/td>\n<\/tr>\n
Fibroblast Activation<\/strong><\/td>\nStudying Palmitoyl Tetrapeptide-7’s effects on dermal fibroblast activity and matrix production<\/td>\n<\/tr>\n
IL-6 Suppression<\/strong><\/td>\nExamining Palmitoyl Tetrapeptide-7’s ability to downregulate interleukin-6 production in inflamed cells<\/td>\n<\/tr>\n
Extracellular Matrix Production<\/strong><\/td>\nExploring Palmitoyl Tetrapeptide-7’s influence on ECM components including collagen, fibronectin, and hyaluronic acid<\/td>\n<\/tr>\n
Anti-Inflammatory Research<\/strong><\/td>\nInvestigating Palmitoyl Tetrapeptide-7’s potential to reduce inflammatory responses via IL-6 modulation<\/td>\n<\/tr>\n
Matrix Remodeling<\/strong><\/td>\nPreclinical research into Palmitoyl Tetrapeptide-7’s potential to influence tissue matrix organization<\/td>\n<\/tr>\n
MMP Inhibition<\/strong><\/td>\nStudying Palmitoyl Tetrapeptide-7’s indirect inhibition of matrix metalloproteinases through IL-6 suppression<\/td>\n<\/tr>\n
Wound Healing Research<\/strong><\/td>\nExploring Palmitoyl Tetrapeptide-7’s potential relevance to tissue repair and regeneration<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Scientific Research on Palmitoyl Tetrapeptide-7<\/h2>\n

Researchers have conducted scientific studies on Palmitoyl Tetrapeptide-7 in both in vitro and in vivo settings, deriving evidence from cell cultures, ex vivo tissue samples, and clinical assessments. The peptide originates from a fragment of human immunoglobulin G, a protein central to immune system function.<\/p>\n

In Vitro Evidence<\/h3>\n

In vitro studies have demonstrated that Palmitoyl Tetrapeptide-7 induces a dose-dependent reduction in IL-6 production in skin cells, with a reported reduction of up to 40%. Furthermore, this effect significantly enhances under UV-induced stress conditions, where an 86% reduction in IL-6 has been documented. Researchers have also documented dose-dependent increases in collagen type I synthesis, with a 120% increase observed at 25 ppm in human dermal fibroblasts.<\/p>\n

Clinical and Ex Vivo Research<\/h3>\n

Furthermore, researchers have investigated Palmitoyl Tetrapeptide-7’s role in matrix remodeling. A methodology study employing in vivo reflectance confocal microscopy (RCM), high-frequency ultrasound, and MALDI-MSI demonstrated that a blend of Palmitoyl Oligopeptide and Palmitoyl Tetrapeptide-7 improved dermal extracellular matrix structure compared to placebo. The peptide blend reduced the thickness of the subepidermal low-echogenic band\u2014a marker of photoaging and ECM degradation\u2014and improved its density as measured by echography.<\/p>\n

In a longer-term clinical assessment, 60 healthy photoaged volunteers (aged 45\u201380) applied a formulation containing Palmitoyl Tetrapeptide-7 and another active ingredient over 12 months. Researchers documented a reduction of facial wrinkles and deposition of fibrillin-rich microfibrils in the papillary dermis of treated skin. Notably, unlike surface-level wrinkle measurements, these imaging endpoints provide direct structural evidence that Palmitoyl Tetrapeptide-7 drives remodeling of the dermal matrix at the microanatomical level.<\/p>\n

Combination Research and Safety<\/h3>\n

Research has also explored the use of Palmitoyl Tetrapeptide-7 in combination with Pal-GHK (Palmitoyl Tripeptide-1) as part of the “Matrixyl 3000” peptide blend. Consequently, researchers often highlight the synergistic action of these two peptides in matrix research formulations.<\/p>\n

Additionally, researchers have investigated the safety profile of Palmitoyl Tetrapeptide-7. The Cosmetic Ingredient Review (CIR) Expert Panel assessed its safety and concluded that it is safe at concentrations not exceeding 0.0015% (15 ppm) in leave-on products. The safety determination relied on a comprehensive review of toxicological data, including acute toxicity, skin and eye irritation, sensitization, phototoxicity, and genotoxicity endpoints.<\/p>\n

Nevertheless, researchers should note that Palmitoyl Tetrapeptide-7 has limited human clinical evidence. Of 14 total studies identified, only one human study with no randomized controlled trials has been documented. Available evidence primarily derives from in vitro and animal research. Therefore, findings should interpret as experimental rather than established. Scientists who buy Palmitoyl Tetrapeptide-7 in Switzerland<\/strong> should remain aware of these evidence considerations.<\/p>\n

Palmitoyl Tetrapeptide-7 Compared With Related Peptides<\/h2>\n\n\n\n\n\n\n\n\n\n
Peptide<\/th>\nRelationship to Palmitoyl Tetrapeptide-7<\/th>\nKey Differences<\/th>\n<\/tr>\n<\/thead>\n
GHK<\/strong><\/td>\nBoth studied for skin and matrix research<\/td>\nGHK is a tripeptide; Palmitoyl Tetrapeptide-7 is a tetrapeptide derived from IgG<\/td>\n<\/tr>\n
GHK-Cu (Copper Peptide)<\/strong><\/td>\nBoth studied for skin and collagen research<\/td>\nGHK-Cu is a copper complex; Palmitoyl Tetrapeptide-7 is a palmitoylated peptide without copper; GHK-Cu may have pro-oxidant concerns<\/td>\n<\/tr>\n
Pal-GHK<\/strong><\/td>\nOften studied in combination with Palmitoyl Tetrapeptide-7<\/td>\nPal-GHK is Palmitoyl Tripeptide-1 (GHK); both are palmitoylated but have different sequences and are often combined in Matrixyl 3000<\/td>\n<\/tr>\n
Pal-AHK<\/strong><\/td>\nBoth are palmitoylated peptides for skin research<\/td>\nPal-AHK has AHK sequence; Palmitoyl Tetrapeptide-7 has GQPR sequence<\/td>\n<\/tr>\n
Palmitoyl Oligopeptide<\/strong><\/td>\nOften studied alongside Palmitoyl Tetrapeptide-7<\/td>\nOften combined with Palmitoyl Tetrapeptide-7 in matrix research formulations<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Research Applications<\/h2>\n

Researchers utilize Palmitoyl Tetrapeptide-7 in a variety of laboratory research applications, primarily in the fields of dermatology, matrix biology, and anti-inflammatory research. Key research applications include:<\/p>\n